As expected, GO pathways yielded a number of biological processes of interest to Alzheimer’s disease, including regulation of amyloid beta formation (pFDR = 0.0014) and regulation of amyloid precursor protein catabolic process (pFDR = 0.00023, Fig. 3d). This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.